Brickell Debt to Equity Ratio Trend from 2010 to 2022

Brickell Biotech Debt to Equity Ratio is increasing over the last several years with stable swings. Debt to Equity Ratio is estimated to finish at 0.23 this year. During the period from 2010 to 2022 Brickell Biotech Debt to Equity Ratio regressed destribution of quarterly values had mean deviationof 0.19 and mean square error of  0.15. Brickell Biotech Gross Profit is most likely to decrease significantly in the upcoming years. The last year's value of Gross Profit was reported at 404,000. The current Interest Expense is estimated to increase to about 63.7 K, while Consolidated Income is projected to decrease to (40.5 M).
  
Check Brickell Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Brickell main balance sheet or income statement drivers, such as Direct Expenses of 1.7 M, Cost of Revenue of 7.3 M or Gross Profit of 414.6 K, as well as many exotic indicators such as PPandE Turnover of 4.69, Accounts Payable Turnover of 2.36 or Accrued Expenses Turnover of 0.54. Brickell financial statements analysis is a perfect complement when working with Brickell Biotech Valuation or Volatility modules. It can also supplement various Brickell Biotech Technical models . Check out Trending Equities.

Brickell Debt to Equity Ratio Breakdown

Showing smoothed Debt to Equity Ratio of Brickell Biotech with missing and latest data points interpolated. Measures the ratio between Total Liabilities and Shareholders Equity.Brickell Biotech's Debt to Equity Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Brickell Biotech's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.003 %10 Years Trend
Increasing
Stable
   Debt to Equity Ratio   
Share
       Timeline  

Brickell Debt to Equity Ratio Regression Statistics

Arithmetic Mean 0.22
Coefficient Of Variation 174.99
Mean Deviation 0.19
Median 0.14
Standard Deviation 0.38
Sample Variance 0.15
Range 1.70
R-Value 0.26
Mean Square Error 0.15
R-Squared 0.07
Significance 0.39
Slope 0.025738
Total Sum of Squares 1.75

Brickell Debt to Equity Ratio History

2012 0.083
2013 0.08
2014 0.12
2015 0.1
2016 0.16
2017 0.27
2018 -0.31
2019 1.4
2020 0.24
2021 0.19
2022 0.23

Be your own money manager

Our tools can tell you how much better you can do entering a position in Brickell Biotech without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Commodity Channel Index Now

   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Pair Trading with Brickell Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brickell Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Dominion Resources could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dominion Resources when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dominion Resources - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dominion Resources to buy it.
The correlation of Dominion Resources is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dominion Resources moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dominion Resources moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dominion Resources can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Tools for Brickell Stock

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go